Dyadic International Inc reports results for the quarter ended September 30 - Earnings Summary

• Dyadic International Inc reported a quarterly adjusted loss of 2 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -6 cents. The mean expectation of three analysts for the quarter was for a loss of 4 cents per share. Wall Street expected results to range from -6 cents to -3 cents per share.

• Revenue fell 61.5% to $449.00 thousand from a year ago; analysts expected $1.43 million.

• Dyadic International Inc's reported EPS for the quarter was a loss of 4 cents​.

• The company reported a quarterly loss of $1.36 million.

• Dyadic International Inc shares had fallen by 12.7% this quarter and lost 58.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 12.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Dyadic International Inc is $5.50, about 93.6% above its last closing price of $0.35

This summary was machine generated from LSEG data November 12 at 10:54 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)